Topical Bromfenac for Intraoperative Miosis and Pain Reduction
Status:
Unknown status
Trial end date:
2019-03-30
Target enrollment:
Participant gender:
Summary
To evaluate the effect of bromfenac ophthalmic solution 0.09% for reduction of intraoperative
miosis and pain in patient who have undergone femtosecond laser-assisted cataract surgery.